October 1st, 2015 COLODETECT, a proposal submitted by the Spanish biotechnology company PROALT, has been selected to receive EU funding from H2020 SME Instrument. In total, the Commission received 580 project proposals from European SMEs by the first cut-off date of the so-called Horizon 2020’s SME Instrument Phase 2. PROALT is the only Spanish company [...]

 January 10th, 2015 Protein Alternatives' project proposal named 'ColoDetect - Development of a novel blood-based diagnostic test for colorectal cancer' has been selected to receive funding from the EU Framework Programme Horizon 2020 SME Instrument. The official communication was received by the company in December and the firm is negotiating the grant conditions at the [...]